Women’s Health Is a Democracy Issue—and a Midterm One

Reproductive health is a key issue in the upcoming midterm elections. Recent developments have brought attention to the topic, including a Supreme Court emergency stay and the resignation of FDA commissioner Marty Makary. The Supreme Court's action paused an attempt by the Fifth Circuit to negate an FDA rule related to mifepristone. Around the same time, Makary announced his resignation amid rumors of a potential firing by President Trump. Further details on these events and their implications for reproductive health are available from Ms. Magazine, a local source covering the issue and its connection to the midterm elections.